Abstract
i.v. bisphosphonates reduce skeletal events in women with bone metastases from breast cancer, but little is known about the prevalence and duration of bisphosphonate use.
Cite
CITATION STYLE
APA
Giordano, S. H., Fang, S., Duan, Z., Kuo, Y.-F., Hortobagyi, G. N., & Goodwin, J. S. (2008). Use of Intravenous Bisphosphonates in Older Women with Breast Cancer. The Oncologist, 13(5), 494–502. https://doi.org/10.1634/theoncologist.2007-0200
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free